Nicolas Boisgerault

929 total citations
25 papers, 688 citations indexed

About

Nicolas Boisgerault is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Nicolas Boisgerault has authored 25 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 11 papers in Oncology and 11 papers in Immunology. Recurrent topics in Nicolas Boisgerault's work include Virus-based gene therapy research (14 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (5 papers). Nicolas Boisgerault is often cited by papers focused on Virus-based gene therapy research (14 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (5 papers). Nicolas Boisgerault collaborates with scholars based in France, United States and United Kingdom. Nicolas Boisgerault's co-authors include Marc Grégoire, Frédéric Tangy, Jean‐François Fonteneau, Chantal Combredet, Christophe Blanquart, Samantha Brandler, Jean-Baptiste Guillerme, David Roulois, L. Cellerin and Alan Melcher and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Nicolas Boisgerault

25 papers receiving 676 citations

Peers

Nicolas Boisgerault
Shyambabu Chaurasiya United States
Laura Evgin United States
Megha Shettigar United States
Karishma Rajani United States
Jennifer Coleman United States
Candice Willmon United States
Shyambabu Chaurasiya United States
Nicolas Boisgerault
Citations per year, relative to Nicolas Boisgerault Nicolas Boisgerault (= 1×) peers Shyambabu Chaurasiya

Countries citing papers authored by Nicolas Boisgerault

Since Specialization
Citations

This map shows the geographic impact of Nicolas Boisgerault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Boisgerault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Boisgerault more than expected).

Fields of papers citing papers by Nicolas Boisgerault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Boisgerault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Boisgerault. The network helps show where Nicolas Boisgerault may publish in the future.

Co-authorship network of co-authors of Nicolas Boisgerault

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Boisgerault. A scholar is included among the top collaborators of Nicolas Boisgerault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Boisgerault. Nicolas Boisgerault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fresquet, Judith, Stéphanie Blandin, Nicolas Boisgerault, et al.. (2024). Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy. Respiratory Research. 25(1). 156–156. 4 indexed citations
2.
Fresquet, Judith, Emmanuelle Com, Charles Pineau, et al.. (2024). Oncolytic viruses alter the biogenesis of tumor extracellular vesicles and influence their immunogenicity. SHILAP Revista de lepidopterología. 32(4). 200887–200887. 8 indexed citations
3.
Jouand, Nicolas, Judith Fresquet, Chantal Combredet, et al.. (2024). Interplay between oncolytic measles virus, macrophages and cancer cells induces a proinflammatory tumor microenvironment. OncoImmunology. 13(1). 2377830–2377830. 3 indexed citations
4.
Boisgerault, Nicolas & Philìppe Bertrand. (2023). Inside PD-1/PD-L1,2 with their inhibitors. European Journal of Medicinal Chemistry. 256. 115465–115465. 13 indexed citations
5.
Arbabian, Atousa, Chantal Combredet, Soizic Dutoit, et al.. (2023). Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells. Cancer Immunology Immunotherapy. 72(10). 3309–3322. 1 indexed citations
6.
Boisgerault, Nicolas, et al.. (2022). The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles. Frontiers in Immunology. 13. 925241–925241. 2 indexed citations
7.
Blanquart, Christophe, et al.. (2021). Delivery of cancer therapies by synthetic and bio-inspired nanovectors. Molecular Cancer. 20(1). 55–55. 96 indexed citations
8.
Foloppe, Johann, Daniel Pouliquen, Marc Grégoire, et al.. (2020). High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma. Molecular Therapy — Oncolytics. 18. 573–578. 6 indexed citations
9.
Boisgerault, Nicolas, Soizic Dutoit, Christophe Blanquart, et al.. (2020). Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus. Journal of Thoracic Oncology. 15(5). 827–842. 38 indexed citations
10.
Tabiasco, Julie, Clément Meiller, L. Cellerin, et al.. (2020). Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma. Journal for ImmunoTherapy of Cancer. 8(1). e000182–e000182. 42 indexed citations
11.
Boisgerault, Nicolas, Soizic Dutoit, Virginie Vignard, et al.. (2017). Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.. OncoImmunology. 7(3). e1407897–e1407897. 24 indexed citations
12.
Guillerme, Jean-Baptiste, Daniela Bruni, Nicolas Boisgerault, et al.. (2016). Oncolytic measles virus induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by human myeloid and plasmacytoid dendritic cells. OncoImmunology. 6(1). e1261240–e1261240. 26 indexed citations
13.
Grégoire, Marc, et al.. (2015). Oncolytic virotherapy for human malignant mesothelioma: recent advances. HAL (Le Centre pour la Communication Scientifique Directe). 133–133. 7 indexed citations
14.
Boisgerault, Nicolas & Richard G. Vile. (2014). Les tumeurs dormantes prises au piège de la récidive. médecine/sciences. 30(4). 355–357. 1 indexed citations
15.
Zaidi, Shane, Kevin G. Shim, Elizabeth J. Ilett, et al.. (2014). Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents. Molecular Therapy. 23(5). 845–856. 11 indexed citations
16.
Guillerme, Jean-Baptiste, Nicolas Boisgerault, David Roulois, et al.. (2013). Measles Virus Vaccine–Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells. Clinical Cancer Research. 19(5). 1147–1158. 97 indexed citations
17.
Kottke, Timothy, Nicolas Boisgerault, Rosa María Díaz, et al.. (2013). Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence. Nature Medicine. 19(12). 1625–1631. 45 indexed citations
18.
Boisgerault, Nicolas, Timothy Kottke, José S. Pulido, et al.. (2013). Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse. Molecular Therapy. 21(8). 1507–1516. 27 indexed citations
19.
Simon, Thomas, Séverine Tanguy‐Royer, Pierre‐Joseph Royer, et al.. (2012). Human dendritic cells sequentially matured with CD4+ T cells as a secondary signal favor CTL and long-term T memory cell responses. Biological Research. 45(1). 33–43. 4 indexed citations
20.
Boisgerault, Nicolas, Frédéric Tangy, & Marc Grégoire. (2010). New Perspectives in Cancer Virotherapy: Bringing the Immune System Into Play. Immunotherapy. 2(2). 185–199. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026